• 1. Sichuan Provincial People’s Hospital, Chengdu 610072, China2. Shuangnan Clinic, Sichuan Provincial People’s Hospital, Chengdu 610072, China;
Export PDF Favorites Scan Get Citation

Objective  To investigate the comprehensive interventions of hypertension in urban community, and to provide evidence for the hypertension intervention of urban community.
Methods  A stratified random sampling method was used to enroll 136 patients with essential hypertension in Shuangnan community of Chengdu city, including 77 males and 59 females. Their average age was 59±3.9. The indexes of compliance index (CI) and control rates for blood pressure by using different kinds of antihypertensive drugs were observed after 3 months. With the same medications, the level and control rates for blood pressure were evaluated at baseline and after 3 months of participation in the program of therapeutic lifestyle changes (TLC).
Results  The group of combination of antihypertensive drugs (n=12) had the highest control rate (83.3%). The group of long-acting calcium antagonist (n=31) had high index of control rate (54.8%) and CI (91.4%). The group of short-acting agents (n=25) had the lowest index of control rate (8.0%) and CI (41.2%). The patients had greater reduction in the level for blood pressure after TLC with significant difference (P lt;0.05).
Conclusion  It is necessary to strengthen and standardize the measures of comprehensive interventions on community treatment of hypertension. The program of reasonable antihypertensive drugs based on TLC should be developed positively.

Citation: CHEN Yang,LIU Mingjiang,YE Zhijun. An Epidemiological Study on the Comprehensive Interventions of Hypertension in Shuangnan Community of Chengdu City. Chinese Journal of Evidence-Based Medicine, 2009, 09(11): 1169-1172. doi: 10.7507/1672-2531.20090212 Copy

  • Previous Article

    Investigation on the Incidence of Urolithiasis in Infants Fed by Melamine-tainted Milk Powder in Gansu Province
  • Next Article

    A Comparative Study between the Newest Essential Medicine Lists of China and the WHO in 2009